Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 10324 clinical trials
featured
Prostate Cancer with/without bone metastasis

Prostate Cancer with/without bone metastasis

  • 136 views
  • 08 Nov, 2020
  • 1 location
featured
Secondary Amenorrhea (Absence of a period)

Secondary Amenorrhea (Absence of a period)

  • 414 views
  • 23 Nov, 2020
  • 1 location
featured
Alliance A071701 Genomically-Guided Treatment Trial in Brain Metastases

People with recurrent or progressive brain metastases may be eligible for this trial.  All tumors will be submitted to the Alliance biorepository for tracking and processing

brain tumor
brain metastases
solid tumor
brain tumors
solid tumors
  • 40 views
  • 24 Jun, 2021
  • 1 location
featured
A study to evaluate preventative secondary stroke treatments.

A study to evaluate preventative secondary stroke treatments.

  • 404 views
  • 23 Nov, 2020
  • 1 location
featured
A Phase 2 Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of Tcelna in Subjects With Secondary Progressive Multiple Sclerosis

A Phase 2 Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of Tcelna in Subjects With Secondary Progressive Multiple Sclerosis

  • 204 views
  • 08 Nov, 2020
  • 1 location
featured
A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

The objectives of this study are to evaluate the safety and efficacy of Zimura intravitreal administration in patients with geographic atrophy secondary to age-related macular degeneration (AMD

  • 0 views
  • 24 Jun, 2021
  • 1 location
featured
A Phase 1/2 Trial of MRTX849 in Combination with TNO155 in Patients with Advanced Solid Tumors with KRAS G12C Mutation

Characterize the safety and tolerability, and evaluate Pharmacokinetics of MRTX849 in combination with TNO155 in patients with advanced solid tumor malignancies with KRAS G12C mutation. MRTX849 is an orally available small molecute inhibitor of KRASG12C. TNO155 is a selective, orally bioavailable allosteric inhibitor of wild type SHP2.

advanced solid tumor
solid tumors
solid tumor
malignant solid tumor
  • 114 views
  • 19 Feb, 2021
  • 10 locations
featured
A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients With Advanced Solid Tumors With KRAS G12C Mutation

Evaluates the safety, tolerability, pharmacokinetics, metabolites, pharmacodynamics, and clinical activity of MRTX849 in patients with advanced solid tumors with a KRAS G12C mutation. MRTX849 is an orally-available small molecule inhibitor of KRAS G12C.

advanced solid tumor
solid tumor
malignant solid tumor
  • 405 views
  • 08 Jul, 2021
  • 73 locations
featured
Moderate to severe Atopic Dermatitis (Eczema)

Eczema is the most common chronic skin condition in the world. Those with eczema are faced with painful patches that itch and are more at risk for developing secondary infections. Individuals

atopic dermatitis/eczema
eczema
  • 0 views
  • 28 Jan, 2021
  • 1 location
featured
  • 614 views
  • 08 Nov, 2020
  • 1 location